Eshoo has been a reliably good vote. Though not a vocal advocate for cannabis or drug reform, she did co-sponsor the SAFE Banking Act, and has been a staunch defender of human rights in general.
Holds office U.S. House District 16
H.R.1588 - Ending Federal Marijuana Prohibition Act of 2019
H.R.1595 - SAFE Banking Act of 2019
H.R.1227 - Ending Federal Marijuana Prohibition Act of 2017 (2017-2018)
H.R.2215 - SAFE Act of 2017 (2017-2018)
"In her opening statement, Chairwoman Anna Eshoo (D-Calif.) noted that the “purpose of today’s hearing is to examine the pressing need for medical research about cannabis and its chemical compounds,” as cannabis, or marijuana, is now legal for medicinal use in 33 states and for recreational use in 11 states and Washington, D.C., but it remains illegal at the federal level. Eshoo added that cannabis’s designation as a Schedule I substance under the Controlled Substances Act (CSA), defined as having no medicinal value, “restricts legitimate medical research” and leaves researchers in a Catch-22." 1/17/20
2021: The Medical Marijuana Research Act, HR 5657
2021: The MORE Act, HR 3617
2021: The SAFE Banking Act, HR 1996
2019: The SAFE Banking Act, HR 1595
2019: Blumenauer/McClintock/Norton Amendment to Protect Legalization
2016: Veterans Equal Access Amendment
2015: Rohrabacher/Farr Amendment to Protect Medical
Email: anna@annaeshoo4congress.com
Phone: 202-225-8104
272 Cannon House Office Building
Washington, DC 20515